Severe Pneumonia: Clinical Trials

34 trials for Severe Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 11 unknown, 5 not yet recruiting, 2 active not recruiting. 12 Not applicable, 2 Phase 2, 2 Phase 3, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable12Completed 7, Unknown 3, Not yet recruiting 2
Phase 22Suspended 1, Terminated 1
Phase 32Suspended 1, Terminated 1
Phase 42Completed 1, Unknown 1
Phase 11Unknown 1

Follow Severe Pneumonia: new trials by email Literature Review of Severe Pneumonia trials Research Report on Severe Pneumonia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Feasibility and Preliminary Efficacy of a Child Life-Based Breathing Exercise Program for Children Recovering From Severe Pneumonia: A Pilot Randomized Controlled Trial
routine health education + a Child Life-Based Breathing Exercise Program, routine health education - Severe Pneumonia
Not applicableNot yet recruitingChildren's Hospital of Fudan University302026-06-012026-05-18
Rapid Identification of Infectious Pathogens in Severe Pneumonia Guided by Bronchoscopic Imaging and Lung CT
Standalone Lung CT for Severe Pneumonia Diagnosis, Bronchoscopic Imaging + Lung CT for Severe Pneumonia diagnosis - Severe Pneumonia
Not yet recruitingThe First Hospital of Jilin University4002026-05-012026-02-09
A Prospective Observational Cohort Study Protocol for Disease Severity Stratification and Prognosis Assessment in Patients With Pneumonia
Severe Pneumonia, Pneumonia
Not yet recruitingZhonghao Fang27002026-05-012026-05-05
Impact of a High-Protein Diet on Clinical Outcomes in Mechanically Ventilated Patients With Severe Pneumonia
Mechanically Ventilated Patients, Severe Pneumonia
Active not recruitingFayoum University602025-10-092026-06-08
AI-Driven Accurate Diagnosis of Pathogens in Severe Pneumonia
Severe Pneumonia
Active not recruitingGuangzhou Medical University10002025-09-182026-03-12
Diagnostic Application of AI-ROSE in Severe Pneumonia
Severe Pneumonia, Bacterial Infections
Enrolling by invitationThe First Affiliated Hospital with Nanjing Medical University1002025-08-312025-08-11
Herpes Simplex Virus Type 1 Infection/Reactivation of Patients With Severe Pneumonia(the HSV-SP Study)
Bronchoalveolar Lavage (BAL) via Fiberoptic Bronchoscopy, throat Swab - Severe Pneumonia
Not yet recruitingSecond Affiliated Hospital of Guangzhou Medical University3232025-06-012025-04-25
Enhancing Pediatric Acute Care Through Adaptive E-Learning and In-Person Skills Practice in Tanzania
Rhapsode Capable™ Platform (Intervention Group), Paper-based ISP (Control Group) - Newborn Resuscitation, Severe Malnutrition
Not applicableNot yet recruitingStanford University1002025-01-062024-10-10
Species-specific Bacterial Detector for Fast Pathogen Diagnosis of Severe Pneumonia
results of SSBD are used to guide antibiotics adjustment - Severe Pneumonia
Not applicableUnknownChinese Medical Association2562024-11-012024-10-26
Rapid Diagnosis of Severe Respiratory Tract Infectious Diseases and Screening of Biomarkers for Stratified Diagnosis
Severe Pneumonia, Biomarkers
UnknownChinese PLA General Hospital1002024-09-012024-08-01
Dynamic Pattern of Etiology, Immunoinflammatory Factors and Their Association With Prognosis of Severe Pneumonia
Severe Pneumonia
UnknownShanghai General Hospital, China6002024-08-012024-08-07
Fiberoptic Bronchoscopy in Severe Ventilator-associated Pneumonia
Other (Conventional Therapy), Fiberoptic Bronchoscopy - Ventilator-Associated Pneumonia, Severe Pneumonia
Not applicableCompletedBenha University1002023-12-152025-09-02
Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
Metagenomics - Severe Pneumonia
RecruitingFirst Affiliated Hospital of Zhejiang University20002023-09-252025-08-07
Research on the Treatment of Severe Community-acquired Pneumonia in Children
Prednisolone Acetate, placebo - Severe Pneumonia
Phase 4UnknownBaoping XU1602023-03-102023-03-14
The Application of Different Sedation Protocols in ICU Patients With Severe Pneumonia
Severe Pneumonia
CompletedXiangya Hospital of Central South University2602023-02-012026-09-21
Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients
Ambroxol Hydrochloride, Standard Therapy - Severe Pneumonia, Community-acquired Pneumonia
Phase 4CompletedNational University of Malaysia322023-01-072023-12-27
Lung Response to a Higher PEEP During Severe Pneumonia: a CT Study
Severe Pneumonia
CompletedIstituto Clinico Humanitas472022-10-012025-08-13
Yinhu Qingwen Granula for the Treatment of Severe CoVID-19
Yinhu Qingwen Granula, Yin Hu Qing Wen Granula(low does), standard medical treatment - COVID-19, Severe Pneumonia
Phase 2 / Phase 3SuspendedZhong Wang1162021-11-012021-07-07
Treatment of COVID-19 Positive/Negative Bangladeshi Adults With Severe Respiratory Complaints by a Locally Made bCPAP: Feasibility Study
Adult bubble CPAP oxygen therapy device - Severe Pneumonia, Acute Respiratory Distress Syndrome
Not applicableCompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh202021-10-082022-08-25
Early Identification and Severity Prediction of Acute Respiratory Infectious Disease
mNGS, Multiplex PCR - Acute Respiratory Infection, Severe Pneumonia
Not applicableUnknownHuashan Hospital4402021-04-042022-05-12

Showing 20 of 34. Sign in to see all of them.

Narrower conditions

Pneumonia (34)  ·  COVID-19 (5)  ·  Disease (3)  ·  Respiratory Distress Syndrome (3)  ·  Community-Acquired Pneumonia (2)  ·  Critical Illness (2)  ·  Hypoxia (2)  ·  Bacterial Infections (1)  ·  Cephalopelvic Disproportion (1)  ·  Child Nutrition Disorders (1)  ·  Dehydration (1)  ·  Disease Progression (1)  ·  Healthcare-Associated Pneumonia (1)  ·  Latent Infection (1)  ·  Malaria (1)

Broader conditions

Infections (34)  ·  Lung Diseases (34)  ·  Respiratory Tract Diseases (34)  ·  Respiratory Tract Infections (33)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Pathologic Processes (9)  ·  Virus Diseases (6)  ·  Coronaviridae Infections (5)  ·  Coronavirus Infections (5)  ·  Nidovirales Infections (5)  ·  Pneumonia, Viral (5)  ·  RNA Virus Infections (5)  ·  Respiration Disorders (4)  ·  Disease Attributes (3)  ·  Bacterial Infections and Mycoses (2)

Interventions

Standard of Care (2)  ·  Ambroxol (1)  ·  Amoxicillin (1)  ·  Control Groups (1)  ·  Oximetry (1)  ·  Prednisolone (1)  ·  Prone Position (1)  ·  prednisolone acetate (1)  ·  reparixin (1)  ·  tocilizumab (1)

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh (3)  ·  Aga Khan University (2)  ·  Xiangya Hospital of Central South University (2)  ·  Asan Medical Center (1)  ·  Baoping XU (1)  ·  Benha University (1)  ·  Children's Hospital of Fudan University (1)  ·  Chinese Medical Association (1)  ·  Chinese PLA General Hospital (1)  ·  Consorcio Centro de Investigación Biomédica en Red (CIBER) (1)  ·  Dompé Farmaceutici S.p.A (1)  ·  Fayoum University (1)  ·  First Affiliated Hospital of Zhejiang University (1)  ·  Guangzhou Medical University (1)  ·  Huashan Hospital (1)

Countries

China (13)  ·  Bangladesh (3)  ·  Italy (3)  ·  Egypt (2)  ·  Pakistan (2)  ·  Brazil (1)  ·  Cambodia (1)  ·  Cameroon (1)  ·  Croatia (1)  ·  Côte d’Ivoire (1)  ·  Malaysia (1)  ·  Mozambique (1)  ·  South Korea (1)  ·  Spain (1)  ·  Tanzania (1)

Top investigators

Adolfine Hokororo, MD (1)  ·  Alberto Zangrillo, MD PhD (1)  ·  Antoni Torres, PhD (1)  ·  Baoping Xu (1)  ·  Dong Shang, M.D. (1)  ·  Eric Wobudeya, MD, PhD (1)  ·  Fatima Mir, FCPS (1)  ·  Hasan Ashraf, MD (1)  ·  Jiang-Rong Huang, M.D. (1)  ·  Jieming Qu, MD,PhD (1)  ·  Lingtong Huang, M.D. (1)  ·  Lorenzo Piemonti, MD PhD (1)  ·  Maryline Bonnet, MD, PhD (1)

Results publications

PMID 20855397, PMID 22285055, PMID 22842561, PMID 26296950, PMID 32853411, PMID 33743621, PMID 34535473, PMID 35603455, PMID 35618953, PMID 35858876, PMID 36395782, PMID 36579494, PMID 38522443, PMID 39814268, PMID 41189033, PMID 41759657, PMID 42829580

NIH funding

R21TW012612 (1)